A citation-based method for searching scientific literature

D Shattuck-Eidens, A Oliphant, M McClure, C McBride, J Gupte, T Rubano, D Pruss, S V Tavtigian, D H Teng, N Adey, M Staebell, K Gumpper, R Lundstrom, M Hulick, M Kelly, J Holmen, B Lingenfelter, S Manley, F Fujimura, M Luce, B Ward, L Cannon-Albright, L Steele, K Offit, A Thomas. JAMA 1997
Times Cited: 287

List of co-cited articles
736 articles co-cited >1

Times Cited
  Times     Co-cited

BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer.
F J Couch, M L DeShano, M A Blackwood, K Calzone, J Stopfer, L Campeau, A Ganguly, T Rebbeck, B L Weber. N Engl J Med 1997

Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.
Thomas S Frank, Amie M Deffenbaugh, Julia E Reid, Mark Hulick, Brian E Ward, Beth Lingenfelter, Kathi L Gumpper, Thomas Scholl, Sean V Tavtigian, Dmitry R Pruss,[...]. J Clin Oncol 2002

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994

Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.
T S Frank, S A Manley, O I Olopade, S Cummings, J E Garber, B Bernhardt, K Antman, D Russo, M E Wood, L Mullineau,[...]. J Clin Oncol 1998

BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.
Donald A Berry, Edwin S Iversen, Daniel F Gudbjartsson, Elaine H Hiller, Judy E Garber, Beth N Peshkin, Caryn Lerman, Patrice Watson, Henry T Lynch, Susan G Hilsenbeck,[...]. J Clin Oncol 2002

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003

The BOADICEA model of genetic susceptibility to breast and ovarian cancer.
A C Antoniou, P P D Pharoah, P Smith, D F Easton. Br J Cancer 2004

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.
M H Gail, L A Brinton, D P Byar, D K Corle, S B Green, C Schairer, J J Mulvihill. J Natl Cancer Inst 1989

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.
Mary-Claire King, Joan H Marks, Jessica B Mandell. Science 2003

Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995

A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO.
D G R Evans, D M Eccles, N Rahman, K Young, M Bulman, E Amir, A Shenton, A Howell, F Lalloo. J Med Genet 2004

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
J P Struewing, P Hartge, S Wacholder, S M Baker, M Berlin, M McAdams, M M Timmerman, L C Brody, M A Tucker. N Engl J Med 1997

A breast cancer prediction model incorporating familial and personal risk factors.
Jonathan Tyrer, Stephen W Duffy, Jack Cuzick. Stat Med 2004

Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.
D A Berry, G Parmigiani, J Sanchez, J Schildkraut, E Winer. J Natl Cancer Inst 1997

Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer.
J Peto, N Collins, R Barfoot, S Seal, W Warren, N Rahman, D F Easton, C Evans, J Deacon, M R Stratton. J Natl Cancer Inst 1999

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
D Ford, D F Easton, D T Bishop, S A Narod, D E Goldgar. Lancet 1994

Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO.
David M Euhus, Kristin C Smith, Linda Robinson, Amy Stucky, Olufunmilayo I Olopade, Shelly Cummings, Judy E Garber, Anu Chittenden, Gordon B Mills, Paula Rieger,[...]. J Natl Cancer Inst 2002

Optimal selection of individuals for BRCA mutation testing: a comparison of available methods.
Paul A James, Rebecca Doherty, Marion Harris, Bickol N Mukesh, Alvin Milner, Mary-Anne Young, Clare Scott. J Clin Oncol 2006

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.
H A Risch, J R McLaughlin, D E Cole, B Rosen, L Bradley, E Kwan, E Jack, D J Vesprini, G Kuperstein, J L Abrahamson,[...]. Am J Hum Genet 2001

Assessing BRCA carrier probabilities in extended families.
Carlos H Barcenas, G M Monawar Hosain, Banu Arun, Jihong Zong, Xiaojun Zhou, Jianfang Chen, Jill M Cortada, Gordon B Mills, Gail E Tomlinson, Alexander R Miller,[...]. J Clin Oncol 2006

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Henry T Lynch, Susan L Neuhausen, Laura van 't Veer, Judy E Garber, Gareth R Evans, Steven A Narod, Claudine Isaacs, Ellen Matloff,[...]. J Clin Oncol 2004

Application of breast cancer risk prediction models in clinical practice.
Susan M Domchek, Andrea Eisen, Kathleen Calzone, Jill Stopfer, Anne Blackwood, Barbara L Weber. J Clin Oncol 2003

A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families.
P Vahteristo, H Eerola, A Tamminen, C Blomqvist, H Nevanlinna. Br J Cancer 2001

BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients.
A Petrij-Bosch, T Peelen, M van Vliet, R van Eijk, R Olmer, M Drüsedau, F B Hogervorst, S Hageman, P J Arts, M J Ligtenberg,[...]. Nat Genet 1997

A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes.
A C Antoniou, P D P Pharoah, G McMullan, N E Day, M R Stratton, J Peto, B J Ponder, D F Easton. Br J Cancer 2002

Genetic analysis of breast cancer in the cancer and steroid hormone study.
E B Claus, N Risch, W D Thompson. Am J Hum Genet 1991

Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.
H Meijers-Heijboer, B van Geel, W L van Putten, S C Henzen-Logmans, C Seynaeve, M B Menke-Pluymers, C C Bartels, L C Verhoog, A M van den Ouweland, M F Niermeijer,[...]. N Engl J Med 2001

The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews.
P Hartge, J P Struewing, S Wacholder, L C Brody, M A Tucker. Am J Hum Genet 1999

Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program.
Marcia S Brose, Timothy R Rebbeck, Kathleen A Calzone, Jill E Stopfer, Katherine L Nathanson, Barbara L Weber. J Natl Cancer Inst 2002

Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.
R Wooster, S L Neuhausen, J Mangion, Y Quirk, D Ford, N Collins, K Nguyen, S Seal, T Tran, D Averill. Science 1994

Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.
Tom Walsh, Silvia Casadei, Kathryn Hale Coats, Elizabeth Swisher, Sunday M Stray, Jake Higgins, Kevin C Roach, Jessica Mandell, Ming K Lee, Sona Ciernikova,[...]. JAMA 2006

Evaluation of models to predict BRCA germline mutations.
H H Kang, R Williams, J Leary, C Ringland, J Kirk, R Ward. Br J Cancer 2006

Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics.
A C Antoniou, R Hardy, L Walker, D G Evans, A Shenton, R Eeles, S Shanley, G Pichert, L Izatt, S Rose,[...]. J Med Genet 2008

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.
Sunil R Lakhani, Marc J Van De Vijver, Jocelyne Jacquemier, Thomas J Anderson, Peter P Osin, Lesley McGuffog, Douglas F Easton. J Clin Oncol 2002

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
Timothy R Rebbeck, Henry T Lynch, Susan L Neuhausen, Steven A Narod, Laura Van't Veer, Judy E Garber, Gareth Evans, Claudine Isaacs, Mary B Daly, Ellen Matloff,[...]. N Engl J Med 2002

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
Noah D Kauff, Jaya M Satagopan, Mark E Robson, Lauren Scheuer, Martee Hensley, Clifford A Hudis, Nathan A Ellis, Jeff Boyd, Patrick I Borgen, Richard R Barakat,[...]. N Engl J Med 2002

Update on the Manchester Scoring System for BRCA1 and BRCA2 testing.
D G R Evans, F Lalloo, A Wallace, N Rahman. J Med Genet 2005

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions.
A C Antoniou, A P Cunningham, J Peto, D G Evans, F Lalloo, S A Narod, H A Risch, J E Eyfjord, J L Hopper, M C Southey,[...]. Br J Cancer 2008

Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer.
William D Foulkes, Ingunn M Stefansson, Pierre O Chappuis, Louis R Bégin, John R Goffin, Nora Wong, Michel Trudel, Lars A Akslen. J Natl Cancer Inst 2003

Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.
L C Hartmann, D J Schaid, J E Woods, T P Crotty, J L Myers, P G Arnold, P M Petty, T A Sellers, J L Johnson, S K McDonnell,[...]. N Engl J Med 1999

Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.